Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pre-Emptive Analgesic Effects of a Selective COX-2 Inhibitor (Rofecoxib) in the Oral Surgery Model

NCT00026819 is registered in ClinicalTrials.gov with National Institute of Dental and Craniofacial Research (NIDCR) as lead sponsor.

NCT NCT00026819
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00026819 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pre-Emptive Analgesic Effects of a Selective COX-2 Inhibitor (Rofecoxib) in the Oral Surgery Model
Lead sponsor
National Institute of Dental and Craniofacial Research (NIDCR)
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2001
Completion date
November 30, 2003
Enrollment
150
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pain